Organic Letters
Letter
Wang, X.-C. Tetrahedron 2015, 71, 2113−2118. (b) Gong, H. − P.;
Zhang, Y.; Da, Y. − X.; Zhang, Z.; Quan, Z. − J.; Wang, X. − C. Chin.
Chem. Lett. 2015, 26, 667−671.
simple preparation and diversification of 2-aryl(alkyl)-
aminopyrimidines, which have been used as prominent
substructures of drug molecules.
(7) For Pd-catalyzed/Cu-mediated Liebeskind and Srogl C−C cross-
coupling of thioether-type species with nucleophilic organometallic
reagents, see: (a) Liebeskind, L. S.; Srogl, J. J. Am. Chem. Soc. 2000, 122,
11260−11261. (b) Savarin, C.; Srogl, J.; Liebeskind, L. S. Org. Lett.
2000, 2, 3229. (c) Savarin, C.; Srogl, J.; Liebeskind, L. S. Org. Lett. 2001,
3, 91−93. (d) Liebeskind, L. S.; Srogl, J. Org. Lett. 2002, 4, 979−981.
(e) Yu, Y.; Liebeskind, L. S. J. Org. Chem. 2004, 69, 3554−3557.
(f) Villalobos, J. M.; Srogl, J.; Liebeskind, L. S. J. Am. Chem. Soc. 2007,
129, 15734−15735. (g) Musaev, D. G.; Liebeskind, L. S. Organometallics
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
Detailed experimental procedures and characterization
1
data of compounds 2a−p, 3a−v and 4 and their H and
́
2009, 28, 4639−4642. For reviews, see: (h) Prokopcova, H.; Kappe, C.
O. Angew. Chem., Int. Ed. 2009, 48, 2276−2286. (i) Wang, L.; He, W.;
Yu, Z. Chem. Soc. Rev. 2013, 42, 599−621.
AUTHOR INFORMATION
Corresponding Author
(8) For the dehydrosulfurative C−C cross-couplings of five- or six-
membered heterocycles possessing thioamide, thiourea, or thiourethane
fragments with boronic acids, stannanes, siloxanes, or terminal alkynes,
see: (a) Lengar, A.; Kappe, C. O. Org. Lett. 2004, 6, 771−774.
(b) Prokopcova, H.; Kappe, C. O. J. Org. Chem. 2007, 72, 4440−4448.
■
Notes
(c) Silva, S.; Sylla, B.; Suzenet, F.; Tatibouet, A.; Rauter, A. P.; Rollin, P.
̈
The authors declare no competing financial interest.
Org. Lett. 2008, 10, 853−856. (d) Silva, S.; Tardy, S.; Routier, S.;
Suzenet, F.; Tatibouet, A.; Rauter, A. P.; Rollin, P. Tetrahedron Lett.
̈
ACKNOWLEDGMENTS
■
2008, 49, 5583−5586. (e) Arshad, N.; Hashim, J.; Kappe, C. O. J. Org.
Chem. 2009, 74, 5118−5121. (f) Guinchard, X.; Roulland, E. Org. Lett.
2009, 11, 4700−4703. (g) Sun, Q.; Suzenet, F.; Guillaumet, G. J. Org.
Chem. 2010, 75, 3473−3476. (h) Sun, Q.; Suzenet, F.; Guillaumet, G.
Tetrahedron Lett. 2012, 53, 2694−2698.
T h i s w o r k w a s s u p p o r t e d b y N R F g r a n t s
(2014R1A1A4A01007933, 2016R1A2A1A05005509) and the
research fund of Chungnam National University.
(9) For the dehydrosulfurative C−C cross-couplings of mercaptopyr-
REFERENCES
■
imidines with terminal alkynes, see: Maltsev, O. V.; Pothig, A.;
̈
(1) Watanabe, M.; Koike, H.; Ishiba, T.; Okada, T.; Seo, S.; Hirai, K.
Bioorg. Med. Chem. 1997, 5, 437−444.
(2) Capdeville, R.; Buchdunger, E.; Zimmermann, J.; Matter, A. Nat.
Rev. Drug. Discovery 2002, 1, 493−502.
(3) For selected references, see: (a) Noble, E. M. M.; Endicott, J. A.;
Johnson, L. N. Science 2004, 303, 1800−1805. (b) Cohen, P. Nat. Rev.
Drug Discovery 2002, 1, 309−315. (c) Saklatvala, J. Curr. Opin.
Pharmacol. 2004, 4, 372−377. (d) Traxler, P.; Bold, G.; Buchdunger,
E.; Caravatti, G.; Furet, P.; Manley, P.; O’Reilly, T.; Wood, J.;
Zimmermann, J. Med. Res. Rev. 2001, 21, 499−519. (e) Lagoja, I. M.
Chem. Biodiversity 2005, 2, 1−50. (f) Han, Y. T.; Choi, G. − I.; Son, D.;
Kim, N. − J.; Yun, H.; Lee, S.; Chang, D. J.; Hong, H. − S.; Kim, H.; Ha,
H. − J.; Kim, Y. − H.; Park, H. − J.; Lee, J.; Suh, Y. − G. J. Med. Chem.
2012, 55, 9120−9135.
Hintermann, L. Org. Lett. 2014, 16, 1282−1285.
(10) There have been two reports where Ar−SMe was used as an
electrophilic coupling partner in Pd-catalyzed C−N cross-coupling with
aryl and alkylamines. (a) Sugahara, T.; Murakami, K.; Yorimitsu, H.;
Osuka, A. Angew. Chem., Int. Ed. 2014, 53, 9329−9333. (b) Gao, K.;
Yorimitsu, H.; Osuka, A. Eur. J. Org. Chem. 2015, 2015, 2678−2682.
(11) Phan, N. H. T.; Sohn, J.-H. Tetrahedron 2014, 70, 7929−7935.
(12) (a) Lee, O. S.; Lee, H.; Kim, H.; Shin, H.; Sohn, J. − H.
Tetrahedron 2015, 71, 2936−2944. (b) Lee, O. K.; Kim, H.; Lee, H. − S.;
Shin, H.; Sohn, J. − H. B. Kor. Chem. Soc. 2016, 37, 242−245.
(13) For selected reviews, see: (a) Singh, K.; Singh, K. Adv. Heterocycl.
Chem. 2012, 105, 223−308. (b) Suresh; Sandhu, J. S. ARKIVOC 2012,
66−133. (c) Wan, J.-P.; Liu, Y. Synthesis 2010, 2010, 3943−3953.
(d) Kappe, C. O. Acc. Chem. Res. 2000, 33, 879−888.
(4) For selected examples, see ref 3f. (a) Kang, F. − A.; Kodah, J.;
Guan, Q.; Li, X.; Murray, W. V. J. Org. Chem. 2005, 70, 1957−1960.
(b) Matloobi, M.; Kappe, C. O. J. Comb. Chem. 2007, 9, 275−284.
(c) Wang, X. − C.; Yang, G. − J.; Quan, Z. − J.; Ji, P. − Y.; Liang, J. − L.;
Ren, R. − G. Synlett 2010, 2010, 1657−1660. (d) Wang, X. − C.; Yang,
G. − J.; Jia, X. − D.; Zhang, Z.; Da, Y. − X.; Quan, Z. − J. Tetrahedron
2011, 67, 3267−3272. (e) Singh, K.; Singh, K.; Wan, B.; Franzblau, S.;
Chibale, K.; Balzarini, J. Eur. J. Med. Chem. 2011, 46, 2290−2294.
(f) Singh, K.; Kaur, H.; Chibale, K.; Balzarini, J.; Little, S.; Bharatam, P.
V. Eur. J. Med. Chem. 2012, 52, 82−97. (g) Quan, Z. − J.; Lv, Y.; Wang,
Z. − J.; Zhang, Z.; Da, Y. − X.; Wang, X. − C. Tetrahedron Lett. 2013, 54,
1884−1887. (h) Quan, Z.; Jing, F.; Zhang, Z.; Da, Y.; Wang, X. Chin. J.
Chem. 2013, 31, 1495−1502. (i) Xing, T.; Wei, K. − J.; Quan, Z. − J.;
Wang, X. − C. Synthesis 2015, 47, 3925−3935. (j) Yang, Q.; Quan, Z.;
Wu, S.; Du, B.; Wang, M.; Li, P.; Zhang, Y.; Wang, X. Tetrahedron 2015,
71, 6124−6134. (k) Wei, K. − J.; Quan, Z.; Zhang, Z.; Da, Y.; Wang, X.
Org. Biomol. Chem. 2016, 14, 2395−2398.
(14) (a) Graham, T. H.; Liu, W.; Shen, D. M. Org. Lett. 2011, 13,
6232−6235. (b) Matsumura, T.; Niwa, T.; Nakada, M. Tetrahedron Lett.
2012, 53, 4313−4316.
(15) Jean, J. V. E.; Nadeg
̀
e, L.; Yves, V. H.; Lutz, T. ARKIVOC 2003,
22−28.
(16) For selected reviews, see: (a) Satoh, T.; Miura, M. Synthesis 2010,
2010, 3395−3409. (b) Rodriguez, N.; Goossen, L. Chem. Soc. Rev. 2011,
40, 5030−5048. (c) Weaver, V.; Recio, A., III; Grenning, A. J.; Tunge, J.
A. Chem. Rev. 2011, 111, 1846−1913. (d) Cornella, J.; Larrosa, I.
Synthesis 2012, 44, 653−676.
(17) Optimization of the reaction conditions is currently underway,
and the results will be reported in due course.
(18) For a possible mechanism of the reaction, see the Supporting
(5) Other strategies to the targets using three-component reaction with
aldehydes, β-ketonitriles, and substituted guanidines lack the efficient
supply of the desired substituted guanidines. Val, C.; Crespo, A.; Yaziji,
V.; Coelho, A.; Azuaje, J.; El Maatougui, A.; Carbajales, C.; Sotelo, E.
ACS Comb. Sci. 2013, 15, 370−378.
(6) The route involving 2-NH2-pyrimidine intermediates for the C−N
cross-coupling to form the targets requires the three-step reaction
sequence for the synthesis of the intermediates from DHPMs.
(a) Zhang, Y.; Quan, Z. − J.; Gong, H. − P.; Da, Y. − X.; Zhang, Z.;
D
Org. Lett. XXXX, XXX, XXX−XXX